MannKind

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MannKind and other ETFs, options, and stocks.

About MNKD

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. 

CEO
Michael E. Castagna
CEOMichael E. Castagna
Employees
592
Employees592
Headquarters
Danbury, Connecticut
HeadquartersDanbury, Connecticut
Founded
1991
Founded1991
Employees
592
Employees592

MNKD Key Statistics

Market cap
1.04B
Market cap1.04B
Price-Earnings ratio
-43.08
Price-Earnings ratio-43.08
Dividend yield
Dividend yield
Average volume
9.17M
Average volume9.17M
High today
$3.60
High today$3.60
Low today
$3.33
Low today$3.33
Open price
$3.53
Open price$3.53
Volume
7.54M
Volume7.54M
52 Week high
$6.51
52 Week high$6.51
52 Week low
$2.23
52 Week low$2.23

Stock Snapshot

The current MannKind(MNKD) stock price is $3.40, with a market capitalization of 1.04B. The stock trades at a price-to-earnings (P/E) ratio of -43.08.

During the trading session on 2026-05-12, MannKind(MNKD) shares reached a daily high of $3.60 and a low of $3.33. At a current price of $3.40, the stock is +2.1% higher than the low and still -5.4% under the high.

Trading activity shows a volume of 7.54M, compared to an average daily volume of 9.17M.

Over the past 52 weeks, MannKind(MNKD) stock has traded between a high of $6.51 and a low of $2.23.

Over the past 52 weeks, MannKind(MNKD) stock has traded between a high of $6.51 and a low of $2.23.

MNKD News

Simply Wall St 3d
Assessing MannKind Valuation After Recent Share Price Rebound And Underperformance

Advertisement MannKind stock reaction and recent performance snapshot MannKind (MNKD) has drawn attention after recent share price swings, with the stock risi...

Assessing MannKind Valuation After Recent Share Price Rebound And Underperformance
TipRanks 4d
MannKind Leans Into Growth Amid Earnings Volatility

MannKind Corporation ((MNKD)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data an...

TipRanks 5d
MannKind price target lowered to $7 from $8 at Mizuho

Mizuho analyst Anthony Petrone lowered the firm’s price target on MannKind (MNKD) to $7 from $8 and keeps an Outperform rating on the shares. Unlock hedge fund...

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

More MNKD News

Seeking Alpha 5d
MannKind drops after Q1 miss

Shares of MannKind Corporation (MNKD) dropped ~8% in extended trading after the Connecticut-based biotech fell short of Street forecasts with its Q1 2026 result...

MannKind drops after Q1 miss
Nasdaq 5d
MannKind Q1 2026 Earnings Transcript

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...

MannKind Q1 2026 Earnings Transcript
Simply Wall St 6d
Undervalued Small Caps With Insider Buying To Consider In May 2026

The United States market has seen a robust performance recently, climbing 1.8% in the last week and 30% over the past year, with earnings projected to grow by 1...

Undervalued Small Caps With Insider Buying To Consider In May 2026

People also own

Based on the portfolios of people who own MNKD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.